# The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis

> **NCT06873711** · — · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 926 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **BIOLOGICAL:** vedolizumab

## Key facts

- **NCT ID:** NCT06873711
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 926 (ACTUAL)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873711, "The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06873711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*